Impact of outpatient clinic ultrasound imaging in the diagnosis and treatment for shoulder impingement: a randomized prospective study.
Name:
Shoulderpaper.doc
Size:
204.8Mb
Format:
Microsoft Word
Description:
Author's peer-reviewed final ...
Affiliation
Department of Rheumatology, Adelaide and Meath Hospital, Tallaght, Dublin 24, Ireland, modelian@gmail.com.Issue Date
2013-11-05Keywords
RHEUMATIC DISORDER
Metadata
Show full item recordCitation
Impact of outpatient clinic ultrasound imaging in the diagnosis and treatment for shoulder impingement: a randomized prospective study. 2013: Rheumatol. Int.Journal
Rheumatology internationalDOI
10.1007/s00296-013-2892-zPubMed ID
24190232Abstract
The use of musculoskeletal ultrasonography (MSUS) in guiding subdeltoid injection has been shown to improve outcome up to 6 weeks in a few small studies. A recent meta-analysis identified the need for further studies with longer-term outcome and larger sample size. This randomized prospective study assessed whether clinic-based MSUS can significantly improve diagnostic accuracy in shoulder pain and whether MSUS-guided shoulder injection results in improved long-term outcomes. One hundred consecutive patients with 125 painful shoulders were recruited. Patients were randomized to receive either sonographic assessment with consequent palpation-guided injection (Group 1, n = 66) or sonographic assessment with a MSUS-guided injection of 40 mg of methylprednisolone acetate (Group 2, n = 59). A blinded rheumatologist (ADF) performed clinical assessments at baseline, 6 and 12 weeks including shoulder function tests (SFTs) (Hawkins-Kennedy test, supraspinatus tendon tenderness), physician global assessment (PGA) and patient visual analogue scores (VAS) for pain (0-10). Eighty patients with 90 symptomatic shoulders completed 12-week follow-up. Twenty patients, 11 (20 shoulders) from the palpation-guided group and 9 (15 shoulders) from the MSUS-guided group, were excluded at 6 weeks either due to requirement for repeat injection or due to surgical referral. Mean age for patients was 57.7 years, and 65 % patients were female; mean shoulder pain duration was 18 weeks (range 14-22 weeks). SFTs, patient VAS and PGA scores for pain improved significantly from baseline in both groups with significantly greater improvements in the MSUS-guided group (44 shoulders) compared to the palpation-guided group (46 shoulders) in all parameters at 6 (p < 0.01) and 12 weeks (p < 0.05). The use of MSUS in guiding subdeltoid injection has been shown to improve outcome up to 6 weeks in a few small studies. A recent meta-analysis identified the need for further studies with longer-term outcome and larger sample size.Item Type
ArticleLanguage
enISSN
1437-160Xae974a485f413a2113503eed53cd6c53
10.1007/s00296-013-2892-z
Scopus Count
Collections
Related articles
- Effects of Ultrasound-Guided Peritendinous and Intrabursal Corticosteroid Injections on Shoulder Tendon Elasticity: A Post Hoc Analysis of a Randomized Controlled Trial.
- Authors: Hsu PC, Chang KV, Wu WT, Wang JC, Özçakar L
- Issue date: 2021 May
- Ultrasound-guided versus blind subacromial corticosteroid and local anesthetic injection in the treatment of subacromial impingement syndrome: A randomized study of efficacy.
- Authors: Akbari N, Ozen S, Şenlikçi HB, Haberal M, Çetin N
- Issue date: 2020
- Randomised controlled trial of single, subacromial injection of methylprednisolone in patients with persistent, post-traumatic impingment of the shoulder.
- Authors: McInerney JJ, Dias J, Durham S, Evans A
- Issue date: 2003 May
- Blind or ultrasound-guided corticosteroid injections and short-term response in subacromial impingement syndrome: a randomized, double-blind, prospective study.
- Authors: Dogu B, Yucel SD, Sag SY, Bankaoglu M, Kuran B
- Issue date: 2012 Aug
- Ultrasound-Guided Versus Blind Subacromial Corticosteroid Injections for Subacromial Impingement Syndrome: A Randomized, Double-Blind Clinical Trial.
- Authors: Cole BF, Peters KS, Hackett L, Murrell GA
- Issue date: 2016 Mar